Join
Live feed
·
INSIDERFilingvia Quantisnow
Pelthos Therapeutics Inc. logo

CFO, Treas & Secty Francis Knuettel Ii returned 13,947 shares to the company and sold $40,265 worth of shares (1,500 units at $26.84), decreasing direct ownership by 42% to 19,525 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PTHS· Pelthos Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTHS (Pelthos Therapeutics Inc.) and more on Quantisnow.